fate therapeutics stock price target

FATE stock quote history news and other vital information to help you with your stock trading and investing. In comparison to the median Healthcare stock FATEs pricesales ratio is 11793 higher now standing at 1452.

Fate Therapeutics Jumped On Supportive Trial Data Nasdaq Fate Seeking Alpha

Is 15507 and for 2032 Mar.

. ET by Tomi Kilgore Fate Therapeutics stock price target raised to 65 from 40 at Truist. 7 2020 at 718 am. An downtrend is forecast for this month with an optimal target price of 370156.

Stocks similar to Fate Therapeutics Inc in the Pharmaceutical. Long term Fate Therapeutics stock forecast for 2022 2023 1 year - 2025 - 2027 5 year - 2030 and 2032 10 year Forecast for 2022 Apr. Is 3589 for 2023 Mar.

Is 1761 for 2026 Mar. The stock is moving within a very wide and. Price Price Target Lowest.

The best long-term short-term Fate Therapeutics share price prognosis for 2022 2023 2024 2025 2026 2027 with daily FATE exchange price projections. Life Is For Living. FATE has a higher upside potential average analyst target price relative to current price than 100215 of stocks in the mid market cap category.

Fate Therapeutics reported interim results from 14 patients treated with FT596 an off-the-shelf immunotherapy made of natural killer cells engineered to target CD19. Analyst Recommendations on FATE THERAPEUTICS INC. Amount of Analyst Coverage Fate Therapeutics has only been the subject of 3 research reports in the past 90 days.

5 Wall Street analysts that have issued a 1 year FATE price target the average FATE price target is 9360 with the highest FATE stock price forecast at 11500 and the lowest FATE stock price forecast at 7400. Over the past 96 months FATEs pricesales ratio has gone. Stock Price Forecast The 18 analysts offering 12-month price forecasts for Fate Therapeutics Inc have a median target of 9900 with a high estimate of 13500 and a low estimate of 4200.

46 rows FATE Stock Trend. Ad 1000 Strong Buy Stocks that Double the SP. Ad Do Your Investments Align with Your Goals.

Morgan Stanley Adjusts Fate Therapeutics Price Target to 52 From 62 Maintains Equalw. Fate Therapeutics Stock Prediction for May 2022. Over the past 96 months FATEs priceearnings ratio has gone down 256.

HC Wainwright Adjusts Fate Therapeutics Price Target to 115 from 122 Keeps Buy Rati. Is 13930 for 2031 Mar. Fate Therapeutics Stock Forecast FATE stock price prediction.

Find the latest Fate Therapeutics Inc. Monthly and daily opening closing maximum and minimum stock price outlook with smart technical analysis. Is 13835 for 2027 Mar.

Find A Dedicated Financial Advisor. Fate Therapeutics NASDAQFATE Price Target Lowered to 7500 at Truist Financial. According to analysts consensus price target of 9500 Fate Therapeutics has a forecasted upside of 1501 from its current price of 3798.

Find the latest Fate Therapeutics Inc. The average price target is 000 with a high estimate of 000 and a low estimate of 000. Based on analysts offering 12 month price targets for FATE in the last 3 months.

13000 The average price target includes all analyst analysis not just the most recent analysis presented in the chart. Wedbush Adjusts Fate Therapeutics Price Target to 77 From 74 Keeps Outperform Ratin. Barclays Increases EOG Resources NYSEEOG Price Target to 14300.

Fate Therapeutics stock price target raised to 88 from 55 at Wedbush Dec. Price target in 14 days. FATE analyst stock forecast price target and recommendation trends with in-depth analysis from research.

In terms of how Fate Therapeutics Inc fares relative to Pharmaceutical Products stocks note that its average analyst price target is greater than 94038 of that group. Nasdaq AT CLOSE 400 PM EDT 041222. Find a Dedicated Financial Advisor Now.

Finally Wedbush upped their target price on shares of Fate Therapeutics from 7400 to 7700 and gave the company an outperform rating. AFTER HOURS 543 PM EDT 041222. Lets Partner Through All Of It.

Why Stocks Are Plummeting This Earnings Season